Targeting Rare and Chronic Kidney Diseases
RARECast - Een podcast door RARECast - Donderdagen
Categorieën:
Tom Frohlich, chief operating officer of Chinook Therapeutics, about rare kidney diseases, the company’s lead therapeutic candidate atrasentan for IgA nephropathy, and the company’s plans for commercialization.
